Bright Historical Balance Sheet

DRUG Stock

USD 36.17 0.60 1.69%

Trend analysis of Bright Minds Biosciences balance sheet accounts such as Total Current Liabilities of 569.8 K or Total Stockholder Equity of 7.9 M provides information on Bright Minds' total assets, liabilities, and equity, which is the actual value of Bright Minds Biosciences to its prevalent stockholders. By breaking down trends over time using Bright Minds balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Bright Minds Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bright Minds Biosciences is a good buy for the upcoming year.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Bright Minds Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

About Bright Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Bright Minds Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Bright Minds Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Bright Minds and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Bright currently owns. An asset can also be divided into two categories, current and non-current.

Bright Minds Balance Sheet Chart

At this time, Bright Minds' Total Stockholder Equity is most likely to increase significantly in the upcoming years. The Bright Minds' current Accounts Payable is estimated to increase to about 478.1 K, while Net Tangible Assets are projected to decrease to roughly 8.4 M.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Total Assets

Total assets refers to the total amount of Bright Minds assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Bright Minds Biosciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Bright Minds balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Bright Minds Biosciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from Bright Minds' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Bright Minds Biosciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Bright Minds Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	25K	41.8K	48.0K	58.0K
Total Assets	6.9M	6.1M	7.0M	8.5M

Other Current Liab Total Assets

Bright Minds balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Good Will	Non Current Liabilities Total	Other Current Assets	Net Invested Capital	Capital Stock	Net Working Capital	Net Receivables	Short Term Investments	Short Long Term Debt Total
Total Assets		0.46	0.78	1.0	0.95	-0.99	-0.59	0.8	1.0	-0.15	1.0	0.46	0.37	0.77	1.0	-0.76	0.77	-0.26	0.47	0.59	0.99	0.77	0.99	-0.13	-0.26	-0.31
Other Current Liab	0.46		0.85	0.42	0.34	-0.44	-0.36	0.86	0.45	0.53	0.45	0.18	0.95	0.85	0.45	-0.3	0.41	-0.12	-0.12	0.4	0.42	0.42	0.41	0.41	-0.12	0.06
Total Current Liabilities	0.78	0.85		0.75	0.74	-0.75	-0.69	1.0	0.77	0.32	0.77	0.53	0.8	1.0	0.78	-0.74	0.78	-0.28	0.0	0.67	0.73	0.78	0.73	0.04	-0.28	-0.24
Total Stockholder Equity	1.0	0.42	0.75		0.95	-0.99	-0.57	0.77	1.0	-0.18	1.0	0.45	0.33	0.74	1.0	-0.75	0.76	-0.25	0.5	0.57	1.0	0.76	0.99	-0.14	-0.25	-0.31
Net Tangible Assets	0.95	0.34	0.74	0.95		-0.93	-0.76	0.74	0.95	-0.04	0.95	0.69	0.25	0.74	0.95	-0.83	0.91	-0.3	0.3	0.68	0.93	0.9	0.93	-0.4	-0.3	-0.49
Net Debt	-0.99	-0.44	-0.75	-0.99	-0.93		0.52	-0.77	-0.99	0.19	-0.99	-0.4	-0.39	-0.74	-0.99	0.71	-0.72	0.12	-0.54	-0.53	-1.0	-0.72	-1.0	0.07	0.12	0.23
Retained Earnings	-0.59	-0.36	-0.69	-0.57	-0.76	0.52		-0.64	-0.58	-0.38	-0.58	-0.93	-0.26	-0.69	-0.59	0.82	-0.95	0.51	0.38	-0.64	-0.52	-0.96	-0.51	0.68	0.51	0.8
Accounts Payable	0.8	0.86	1.0	0.77	0.74	-0.77	-0.64		0.79	0.27	0.79	0.47	0.81	1.0	0.79	-0.72	0.74	-0.26	0.06	0.66	0.75	0.74	0.75	0.1	-0.26	-0.18
Cash	1.0	0.45	0.77	1.0	0.95	-0.99	-0.58	0.79		-0.16	1.0	0.45	0.37	0.76	1.0	-0.75	0.76	-0.25	0.48	0.58	0.99	0.76	0.99	-0.13	-0.25	-0.31
Non Current Assets Total	-0.15	0.53	0.32	-0.18	-0.04	0.19	-0.38	0.27	-0.16		-0.16	0.43	0.42	0.34	-0.16	0.1	0.28	-0.14	-0.63	0.38	-0.21	0.28	-0.22	-0.11	-0.14	-0.11
Cash And Short Term Investments	1.0	0.45	0.77	1.0	0.95	-0.99	-0.58	0.79	1.0	-0.16		0.45	0.37	0.76	1.0	-0.75	0.76	-0.25	0.48	0.58	0.99	0.76	0.99	-0.13	-0.25	-0.31
Common Stock Shares Outstanding	0.46	0.18	0.53	0.45	0.69	-0.4	-0.93	0.47	0.45	0.43	0.45		0.09	0.54	0.46	-0.73	0.91	-0.42	-0.39	0.7	0.38	0.91	0.37	-0.79	-0.42	-0.73
Other Stockholder Equity	0.37	0.95	0.8	0.33	0.25	-0.39	-0.26	0.81	0.37	0.42	0.37	0.09		0.8	0.37	-0.29	0.33	0.09	-0.13	0.24	0.34	0.32	0.34	0.49	0.09	0.14
Total Liab	0.77	0.85	1.0	0.74	0.74	-0.74	-0.69	1.0	0.76	0.34	0.76	0.54	0.8		0.77	-0.73	0.78	-0.28	-0.02	0.68	0.71	0.78	0.71	0.04	-0.28	-0.24
Total Current Assets	1.0	0.45	0.78	1.0	0.95	-0.99	-0.59	0.79	1.0	-0.16	1.0	0.46	0.37	0.77		-0.76	0.77	-0.25	0.47	0.59	0.99	0.77	0.99	-0.13	-0.25	-0.31
Intangible Assets	-0.76	-0.3	-0.74	-0.75	-0.83	0.71	0.82	-0.72	-0.75	0.1	-0.75	-0.73	-0.29	-0.73	-0.76		-0.86	0.4	0.03	-0.6	-0.7	-0.86	-0.7	0.45	0.4	0.59
Common Stock	0.77	0.41	0.78	0.76	0.91	-0.72	-0.95	0.74	0.76	0.28	0.76	0.91	0.33	0.78	0.77	-0.86		-0.39	-0.12	0.73	0.71	1.0	0.71	-0.57	-0.39	-0.67
Good Will	-0.26	-0.12	-0.28	-0.25	-0.3	0.12	0.51	-0.26	-0.25	-0.14	-0.25	-0.42	0.09	-0.28	-0.25	0.4	-0.39		0.28	-0.42	-0.17	-0.44	-0.17	0.43	1.0	0.6
Non Current Liabilities Total	0.47	-0.12	0.0	0.5	0.3	-0.54	0.38	0.06	0.48	-0.63	0.48	-0.39	-0.13	-0.02	0.47	0.03	-0.12	0.28		0.05	0.55	-0.14	0.56	0.37	0.28	0.46
Other Current Assets	0.59	0.4	0.67	0.57	0.68	-0.53	-0.64	0.66	0.58	0.38	0.58	0.7	0.24	0.68	0.59	-0.6	0.73	-0.42	0.05		0.52	0.73	0.52	-0.3	-0.42	-0.16
Net Invested Capital	0.99	0.42	0.73	1.0	0.93	-1.0	-0.52	0.75	0.99	-0.21	0.99	0.38	0.34	0.71	0.99	-0.7	0.71	-0.17	0.55	0.52		0.71	1.0	-0.08	-0.17	-0.25
Capital Stock	0.77	0.42	0.78	0.76	0.9	-0.72	-0.96	0.74	0.76	0.28	0.76	0.91	0.32	0.78	0.77	-0.86	1.0	-0.44	-0.14	0.73	0.71		0.7	-0.58	-0.44	-0.69
Net Working Capital	0.99	0.41	0.73	0.99	0.93	-1.0	-0.51	0.75	0.99	-0.22	0.99	0.37	0.34	0.71	0.99	-0.7	0.71	-0.17	0.56	0.52	1.0	0.7		-0.08	-0.17	-0.25
Net Receivables	-0.13	0.41	0.04	-0.14	-0.4	0.07	0.68	0.1	-0.13	-0.11	-0.13	-0.79	0.49	0.04	-0.13	0.45	-0.57	0.43	0.37	-0.3	-0.08	-0.58	-0.08		0.43	0.83
Short Term Investments	-0.26	-0.12	-0.28	-0.25	-0.3	0.12	0.51	-0.26	-0.25	-0.14	-0.25	-0.42	0.09	-0.28	-0.25	0.4	-0.39	1.0	0.28	-0.42	-0.17	-0.44	-0.17	0.43		0.6
Short Long Term Debt Total	-0.31	0.06	-0.24	-0.31	-0.49	0.23	0.8	-0.18	-0.31	-0.11	-0.31	-0.73	0.14	-0.24	-0.31	0.59	-0.67	0.6	0.46	-0.16	-0.25	-0.69	-0.25	0.83	0.6

Click cells to compare fundamentals

Bright Minds Account Relationship Matchups

Bright Minds balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	20.0M	12.1M	6.9M	6.1M	7.0M	8.5M
Other Current Liab	42K	158.2K	25K	41.8K	48.0K	58.0K
Total Current Liabilities	638.6K	1.5M	280.9K	528.7K	608.0K	569.8K
Total Stockholder Equity	19.4M	10.5M	6.6M	5.5M	6.4M	7.9M
Net Debt	(19.8M)	(11.5M)	(6.7M)	(5.6M)	(5.0M)	(5.3M)
Retained Earnings	(9.2M)	(24.2M)	(31.5M)	(34.3M)	(30.9M)	(29.4M)
Accounts Payable	596.6K	1.2M	182.3K	407.5K	468.7K	478.1K
Cash	19.8M	11.6M	6.7M	5.7M	6.6M	8.2M
Cash And Short Term Investments	19.8M	11.6M	6.7M	5.7M	6.6M	8.2M
Common Stock Shares Outstanding	1.8M	2.5M	3.7M	4.3M	5.0M	2.7M
Liabilities And Stockholders Equity	20.0M	12.1M	6.9M	6.1M	7.0M	8.5M
Other Stockholder Equity	(33.7K)	10.5T	831.8K	455.6K	523.9K	497.7K
Total Liab	638.6K	1.5M	280.9K	568.3K	653.5K	590.3K
Total Current Assets	20.0M	11.9M	6.8M	6.0M	6.9M	8.4M
Accumulated Other Comprehensive Income	1.6M	2.5M	3.4M	4.0M	4.6M	4.8M
Common Stock	27.1M	32.2M	33.9M	35.4M	40.7M	23.8M
Non Current Liabilities Total	596.6K	72.0K	0.0	39.6K	35.6K	33.8K
Other Current Assets	168.2K	164.4K	27.7K	216.6K	249.1K	144.2K
Net Invested Capital	19.4M	10.5M	6.6M	5.5M	5.0M	6.8M
Capital Stock	27.1M	32.2M	33.9M	35.4M	40.7M	28.5M
Net Working Capital	19.4M	10.5M	6.5M	5.5M	4.9M	6.8M

Currently Active Assets on Macroaxis

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria
HMY	Harmony Gold Mining
FSM	Fortuna Silver Mines

When determining whether Bright Minds Biosciences is a strong investment it is important to analyze Bright Minds' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bright Minds' future performance. For an informed investment choice regarding Bright Stock, refer to the following important reports:

How To Invest In Bright

Details

Is Bright Stock a good investment?

Details

What is Bright Minds' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.45)

Return On Assets

(0.29)

Return On Equity

(0.52)

The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bright Minds' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bright Historical Balance Sheet

About Bright Balance Sheet Analysis

Bright Minds Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Bright Minds balance sheet Correlations

Bright Minds Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bright Minds balance sheet Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Accounts Payable	+ 1.0	Total Current Liabilities
Total Liab	+ 1.0	Total Current Liabilities

Net Working Capital	- 1.0	Net Debt
Net Invested Capital	- 1.0	Net Debt
Total Current Assets	- 0.99	Net Debt
Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Net Debt	- 0.99	Total Stockholder Equity